Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$10.31 USD
+0.03 (0.29%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $10.30 -0.01 (-0.10%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | 0.03 |
EPS Last Quarter | -0.02 |
Last EPS Surprise | 66.67% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.20 |
Next Year | 0.53 |
EPS (TTM) | -0.35 |
P/E (F1) | 51.40 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 120.76M | 132.89M | 509.15M | 630.47M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 121.66M | 133.00M | 510.29M | 689.27M |
Low Estimate | 119.40M | 132.77M | 507.70M | 601.11M |
Year ago Sales | 94.50M | 103.50M | 399.36M | 509.15M |
Year over Year Growth Est. | 27.78% | 28.39% | 27.49% | 23.83% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03 | 0.07 | 0.20 | 0.53 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | 0.03 | 0.05 | 0.19 | 0.28 |
High Estimate | 0.09 | 0.12 | 0.35 | 0.84 |
Low Estimate | 0.00 | 0.05 | 0.12 | 0.28 |
Year ago EPS | -0.15 | -0.07 | -0.51 | 0.20 |
Year over Year Growth Est. | 120.00% | 200.00% | 139.22% | 165.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.03 | 0.07 | 0.20 | 0.53 |
7 Days Ago | 0.03 | 0.07 | 0.20 | 0.53 |
30 Days Ago | 0.03 | 0.07 | 0.20 | 0.53 |
60 Days Ago | 0.04 | 0.08 | 0.23 | 0.51 |
90 Days Ago | 0.06 | 0.10 | 0.33 | 0.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.03 | 0.07 | 0.20 | 0.53 |
Zacks Consensus Estimate | 0.03 | 0.07 | 0.20 | 0.53 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.02 | -0.11 | -0.07 | -0.15 | NA |
Estimate | -0.06 | -0.06 | -0.08 | -0.12 | NA |
Difference | 0.04 | -0.05 | 0.01 | -0.03 | -0.01 |
Surprise | 66.67% | -83.33% | 12.50% | -25.00% | -7.29% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more